For instance, C. R. Oliva et al. reported that IGFBP6 regulates temozolomide (TMZ) resistance in glioblastoma through its paracrine effects on IGF2/IGF-1R signalling [34]. This evidence concerns the gene IGFBP6 and glioblastoma.